✦ LIBER ✦

Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients

✍ Scribed by Nagako Kitagawa; Yutaka Yano; Esteban C. Gabazza; Nelson E. Bruno; Rika Araki; Kazutaka Matsumoto; Akira Katsuki; Yasuko Hori; Kaname Nakatani; Osamu Taguchi; Yasuhiro Sumida; Koji Suzuki; Yukihiko Adachi

Book ID: 116405544
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 266 KB
Volume: 73
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2005.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of thrombin-activatable fibrin

Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients

✍ I. FERNANDEZ-CADENAS; J. ALVAREZ-SABIN; M. RIBO; M. RUBIERA; M. MENDIOROZ; C. A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

Postprandial thrombin activatable fibrin

Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients

✍ Mercedes Rigla; Ana Maria Wägner; Montserrat Borrell; José Mateo; Jordi Foncuber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Study on effect of different dosages of

Study on effect of different dosages of ligustrazine on level of plasminogen activator inhibitor-1 activity in type 2 diabetes mellitus patients

✍ Xue Xian-zhong; Zhang Zhao-hua; Xing Xiao-yan 📂 Article 📅 2003 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 444 KB

A study on the action of vitamin E suppl

A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients

✍ Arianna Vignini; Laura Nanetti; Cinzia Moroni; Roberto Testa; Cristina Sirolla; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Effects of gliclazide on platelet aggreg

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus

✍ Hiroyuki Konya; Yoshikazu Hasegawa; Tomoya Hamaguchi; Kahori Satani; Akiko Umeha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 439 KB

1P-0066 Severity of coronary arterial st

1P-0066 Severity of coronary arterial stenotic changes correlates with increases in plasma insulin and plasminogen activator inhibitor 1 levels in patients with type 2 diabetes

✍ Kanjuh, V.; Lalic, N.; Ostojic, M.; Lalic, K.; Beleslin, B.; Kanjuh, S.; Jotic, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 81 KB